• Something wrong with this record ?

Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating

S. Sivcev, B. Slavikova, M. Ivetic, M. Knezu, E. Kudova, H. Zemkova,

. 2020 ; 202 (-) : 105725. [pub] 20200708

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

The family of ATP-gated purinergic P2X receptors comprises seven bunits (P2X1-7) that are unevenly distributed in the central and peripheral nervous systems as well as other organs. Endogenous modulators of P2X receptors are phospholipids, steroids and neurosteroids. Here, we analyzed whether bile acids, which are natural products derived from cholesterol, affect P2X receptor activity. We examined the effects of primary and secondary bile acids and newly synthesized derivatives of lithocholic acid on agonist-induced responses in HEK293T cells expressing rat P2X2, P2X4 and P2X7 receptors. Electrophysiology revealed that low micromolar concentrations of lithocholic acid and its structural analog 4-dafachronic acid strongly inhibit ATP-stimulated P2X2 but potentiate P2X4 responses, whereas primary bile acids and other secondary bile acids exhibit no or reduced effects only at higher concentrations. Agonist-stimulated P2X7 responses are significantly potentiated by lithocholic acid at moderate concentrations. Structural modifications of lithocholic acid at positions C-3, C-5 or C-17 abolish both inhibitory and potentiation effects to varying degrees, and the 3α-hydroxy group contributes to the ability of the molecule to switch between potentiation and inhibition. Lithocholic acid allosterically modulates P2X2 and P2X4 receptor sensitivity to ATP, reduces the rate of P2X4 receptor desensitization and antagonizes the effect of ivermectin on P2X4 receptor deactivation. Alanine-scanning mutagenesis of the upper halve of P2X4 transmembrane domain-1 revealed that residues Phe48, Val43 and Tyr42 are important for potentiating effect of lithocholic acid, indicating that modulatory sites for lithocholic acid and ivermectin partly overlap. Lithocholic acid also inhibits ATP-evoked currents in pituitary gonadotrophs expressing native P2X2, and potentiates ATP currents in nonidentified pituitary cells expressing P2X4 receptors. These results indicate that lithocholic acid is a bioactive steroid that may help to further unveil the importance of the P2X2, and P2X4 receptors in many physiological processes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027893
003      
CZ-PrNML
005      
20210114152549.0
007      
ta
008      
210105s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jsbmb.2020.105725 $2 doi
035    __
$a (PubMed)32652201
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sivcev, Sonja $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic.
245    10
$a Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating / $c S. Sivcev, B. Slavikova, M. Ivetic, M. Knezu, E. Kudova, H. Zemkova,
520    9_
$a The family of ATP-gated purinergic P2X receptors comprises seven bunits (P2X1-7) that are unevenly distributed in the central and peripheral nervous systems as well as other organs. Endogenous modulators of P2X receptors are phospholipids, steroids and neurosteroids. Here, we analyzed whether bile acids, which are natural products derived from cholesterol, affect P2X receptor activity. We examined the effects of primary and secondary bile acids and newly synthesized derivatives of lithocholic acid on agonist-induced responses in HEK293T cells expressing rat P2X2, P2X4 and P2X7 receptors. Electrophysiology revealed that low micromolar concentrations of lithocholic acid and its structural analog 4-dafachronic acid strongly inhibit ATP-stimulated P2X2 but potentiate P2X4 responses, whereas primary bile acids and other secondary bile acids exhibit no or reduced effects only at higher concentrations. Agonist-stimulated P2X7 responses are significantly potentiated by lithocholic acid at moderate concentrations. Structural modifications of lithocholic acid at positions C-3, C-5 or C-17 abolish both inhibitory and potentiation effects to varying degrees, and the 3α-hydroxy group contributes to the ability of the molecule to switch between potentiation and inhibition. Lithocholic acid allosterically modulates P2X2 and P2X4 receptor sensitivity to ATP, reduces the rate of P2X4 receptor desensitization and antagonizes the effect of ivermectin on P2X4 receptor deactivation. Alanine-scanning mutagenesis of the upper halve of P2X4 transmembrane domain-1 revealed that residues Phe48, Val43 and Tyr42 are important for potentiating effect of lithocholic acid, indicating that modulatory sites for lithocholic acid and ivermectin partly overlap. Lithocholic acid also inhibits ATP-evoked currents in pituitary gonadotrophs expressing native P2X2, and potentiates ATP currents in nonidentified pituitary cells expressing P2X4 receptors. These results indicate that lithocholic acid is a bioactive steroid that may help to further unveil the importance of the P2X2, and P2X4 receptors in many physiological processes.
650    _2
$a zvířata $7 D000818
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a hypothalamus $x cytologie $x účinky léků $x fyziologie $7 D007031
650    _2
$a gating iontového kanálu $x účinky léků $7 D015640
650    _2
$a kyselina lithocholová $x analogy a deriváty $x farmakologie $7 D008095
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a neurony $x účinky léků $x fyziologie $7 D009474
650    _2
$a adenohypofýza $x cytologie $x účinky léků $x fyziologie $7 D010903
650    _2
$a agonisté purinergního receptoru P2X $x farmakologie $7 D058911
650    _2
$a antagonisté purinergních receptorů P2X $x farmakologie $7 D058920
650    _2
$a potkani Wistar $7 D017208
650    _2
$a purinergní receptory P2X2 $x fyziologie $7 D058476
650    _2
$a purinergní receptory P2X4 $x fyziologie $7 D058848
650    _2
$a purinergní receptory P2X7 $x fyziologie $7 D058486
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Slavikova, Barbora $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Ivetic, Milorad $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Knezu, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Zemkova, Hana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: zemkova@biomed.cas.cz.
773    0_
$w MED00004950 $t The Journal of steroid biochemistry and molecular biology $x 1879-1220 $g Roč. 202, č. - (2020), s. 105725
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32652201 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152547 $b ABA008
999    __
$a ok $b bmc $g 1608228 $s 1119073
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 202 $c - $d 105725 $e 20200708 $i 1879-1220 $m Journal of steroid biochemistry and molecular biology $n J Steroid Biochem Mol Biol $x MED00004950
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...